Precision Medicine from the Inside Out
Our Live Biotherapeutic Products (LBPs) represent a paradigm shift in medicine. Unlike traditional small molecules that target a single pathway, our engineered microbial consortia act as bio-active factories within the gut, dynamically restoring metabolic function and immune homeostasis.
Single Strain Purity
Isolating the most potent therapeutic strains with defined mechanisms of action.
High Potency Formulations
Lyophilized delivery systems ensuring maximum viability and colonization.
Clinical Candidates
We are advancing a robust pipeline of defined bacterial consortia targeting major unmet needs in gastroenterology and metabolic health.
Recurrent C. difficile Infection
ORALMild-to-Moderate Ulcerative Colitis
ORALIBD / Irritable Bowel Syndrome
ORALNon-Alcoholic Fatty Liver Disease
ORAL* Pipeline status as of April 2026
Publications
Explore our latest peer-reviewed research and clinical data presentations.
View Publications →Partnering
Interested in collaborating on our LBP platform? We are open to strategic partnerships.
Contact Business Dev →Clinical Trials
Information for patients and investigators regarding our ongoing clinical studies.
Find a Study →